Manufacturers Life Insurance Company, The Akero Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$109 Billion
Q4 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 124,592 shares of AKRO stock, worth $6.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

124,592

Previous 96,549 29.05%

Holding current value

$6.12 Million

Previous $2.77 Million 25.17%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$26.75 - $35.28 $750,150 - $989,357	28,043 Added 29.05%	124,592 $3.47 Million
Q3 2024 Nov 13, 2024	SELL	$21.45 - $29.34 $227,863 - $311,678	-10,623 Reduced 9.91%	96,549 $2.77 Million
Q2 2024 Aug 14, 2024	BUY	$18.31 - $24.62 $406,390 - $546,440	22,195 Added 26.12%	107,172 $2.51 Million
Q1 2024 May 14, 2024	BUY	$17.76 - $31.18 $247,787 - $435,023	13,952 Added 19.64%	84,977 $2.15 Million
Q4 2023 Feb 13, 2024	SELL	$11.38 - $50.33 $63,591 - $281,244	-5,588 Reduced 7.29%	71,025 $1.66 Million
Q3 2023 Nov 15, 2023	BUY	$41.19 - $52.25 $501,817 - $636,561	12,183 Added 18.91%	76,613 $3.88 Million
Q2 2023 Aug 11, 2023	BUY	$36.89 - $56.88 $338,908 - $522,556	9,187 Added 16.63%	64,430 $3.01 Million
Q1 2023 May 15, 2023	BUY	$37.27 - $50.24 $90,007 - $121,329	2,415 Added 4.37%	57,658 $2.21 Million
Q4 2022 Aug 11, 2023	BUY	$33.44 - $54.8 $1.05 Million - $1.72 Million	31,417 Added 131.86%	55,243 $3.03 Million
Q4 2022 Feb 13, 2023	BUY	$33.44 - $54.8 $1.05 Million - $1.72 Million	31,417 Added 131.86%	55,243 $3.03 Million
Q3 2022 Aug 11, 2023	BUY	$10.15 - $34.05 $115,121 - $386,195	11,342 Added 90.85%	23,826 $811,000
Q3 2022 Nov 03, 2022	BUY	$10.15 - $34.05 $115,121 - $386,195	11,342 Added 90.85%	23,826 $761,000
Q2 2022 Aug 11, 2023	BUY	$8.0 - $15.01 $6,904 - $12,953	863 Added 7.43%	12,484 $117,000
Q2 2022 Aug 15, 2022	BUY	$8.0 - $15.01 $6,904 - $12,953	863 Added 7.43%	12,484 $118,000
Q1 2022 Aug 11, 2023	SELL	$12.97 - $22.26 $597,099 - $1.02 Million	-46,037 Reduced 79.84%	11,621 $164,000
Q1 2022 May 20, 2022	SELL	$12.97 - $22.26 $33,047 - $56,718	-2,548 Reduced 17.98%	11,621 $165,000
Q4 2021 Feb 16, 2022	SELL	$19.87 - $26.24 $4,232 - $5,589	-213 Reduced 1.48%	14,169 $302,000
Q3 2021 Nov 12, 2021	SELL	$18.65 - $25.46 $16,374 - $22,353	-878 Reduced 5.75%	14,382 $321,000
Q2 2021 Aug 12, 2021	BUY	$24.81 - $32.35 $166,996 - $217,747	6,731 Added 78.92%	15,260 $379,000
Q1 2021 May 03, 2021	SELL	$24.04 - $34.19 $7,091 - $10,086	-295 Reduced 3.34%	8,529 $247,000
Q4 2020 Feb 12, 2021	BUY	$25.12 - $29.89 $22,783 - $27,110	907 Added 11.46%	8,824 $228,000
Q3 2020 Nov 09, 2020	BUY	$30.79 - $39.92 $243,764 - $316,046	7,917 New	7,917 $244,000

Others Institutions Holding AKRO

# of Institutions

210

Shares Held

74.3M

Call Options Held

321K

Put Options Held

558K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $2.28B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Akero Therapeutics, Inc. Transaction History